Supriya Lifescience Ltd.
NSE: SUPRIYA · Healthcare
Sector
Healthcare
Size band
Small cap
Market cap
4,900cr
P/E
26.4
ROE
20.7%
Dividend yield
0.2%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Supriya Lifescience Ltd. | 25.0% | 31.0% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Supriya Lifescience Ltd..
On air
3 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| Zee BusinessZee Business · no registration attached | 20 Aug | +16.9% | -6.2% | still open |
| Zee BusinessZee Business · no registration attached | 20 Aug | +17.1% | -6.1% | still open |
| Zee BusinessZee Business · no registration attached | 20 Aug | +24.4% | -6.1% | still open |
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 68.3 | 68.3 | 68.3 | 68.3 | 0.0 |
| Foreign institutions | 6.2 | 5.2 | 5.2 | 5.5 | +0.7 |
| Domestic institutions | 5.3 | 5.7 | 5.0 | 5.2 | +0.1 |
| Retail & others | 20.2 | 20.8 | 21.5 | 21.0 | −0.8 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 246- General Updates2 Sept 2026
- Enclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered. Kindly take the same on record.2 Sept 2026
- General Updates2 Sept 2026
- Enclosed herewith disclosure under Regulation 30.2 Sept 2026
- Copy of Newspaper Publication2 Sept 2026
- Copy of Newspaper Public for dispatch of AGM Notice and Annual Report.2 Sept 2026
- Clarification - Financial Results2 Sept 2026RoutineResults
- Business Responsibility and Sustainability Report for FY 2025-261 Sept 2026
- Shareholders meeting1 Sept 2026
- Notice of 18th AGM of the Company.1 Sept 2026
- Annual Report1 Sept 2026
- Copy of Newspaper Publication27 Aug 2026
- Copy of Newspaper Publication is enclosed.27 Aug 2026
- Record Date26 Aug 2026
- Enclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.26 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates18 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates14 Aug 2026
- Copy of Newspaper Publication14 Aug 2026
- Press Release13 Aug 2026
- Press Release for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed herewith.13 Aug 2026
- Updates13 Aug 2026
- Investor Presentation13 Aug 2026
- Outcome of Board Meeting13 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
- Copy of Newspaper Publication23 Jul 2026
The 25 most recent of 246 filings we hold for SUPRIYA, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.